Polaprezinc vs Azulene
Oral mucositis (any severity) · Patients with cancer receiving radiotherapy, chemotherapy or targeted therapies
Polaprezinc showed no clear difference in oral mucositis (any severity) compared with azulene; GRADE not reported.
1 finding from 1 review
- Interventions for preventing oral mucositis for patients with cancer receiving treatment 2011 · Cochrane All outcomesMedian 28 daysRR 0.82 [0.63, 1.06]1 study · 31 participantsGRADE not reported